baber/WOPTO huggingface dataset:
Patent MX-2018013222-A (MX)
Title: Interferon beta antibodies and uses thereof.
Inventor: EDWARD ROLAND LAVALLIE
IPC: A61K39/00
Filed: 2017-04-28
Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFNp). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.
Patent MX-2018015558-A (MX)
Title: Metallic burner tiles.
Inventor: VASILY SIMANZHENKOV
IPC: F23D14/66
Filed: 2017-06-01
Abstract: The present disclosure seeks to provide a metallic burner tile for use in industrial processes such as cracking. The tile is substantially metallic (e.g. more than 80%) with the balance being ceramic coating on surfaces exposed to high temperature. The tile is lighter and more durable than the current ceramic burners.
Patent MX-2018016412-A (MX)
Title: Separation of hydrocarbons from particulate matter using salt and polymer.
Inventor: ARON LUPINSKY
IPC: C10G21/08
Filed: 2017-06-22
Abstract: Separating hydrocarbon from compositions including hydrocarbon and solids such as oil sands, oil sands by products, asphalt compositions, etc. includes treating such compositions with a mixture including a water soluble salt. The mixture can optionally also include polymer flocculent and/or organic diluent. The hydrocarbon separated can be in high yields and with a low solid fines content.
Patent MX-2019000735-A (MX)
Title: Tetrahydroisoquinoline kappa opioid antagonists.
Inventor: FRANK IVY CARROLL
IPC: A61K31/472
Filed: 2017-09-15
Abstract: Potent opioid receptor antagonists of formula (I) and their use as pharmacotherapies for treating depression, anxiety, schizophrenia, eating disorders, and addiction to cocaine, methamphetamine, nicotine, alcohol, and opiates are disclosed. More specifically, the disclosure provides potent and selective kappa opioid receptor antagonist compounds, pharmaceutical compositions of those compounds and uses of those compounds to ameliorate or treat addictions, eating disorders, etc.
Patent MX-2019001283-A (MX)
Title: Method, device and computer program for primary cell change.
Inventor: RUI FAN
IPC: H04W36/00
Filed: 2016-08-03
Abstract: Embodiments of the disclosure generally relate to primary cell change. A network device detects whether layer 2 context being kept and/or one or more serving secondary cells remain for a primary cell change for a terminal device. Then, the network device configures a message indicating the primary cell change based on the detecting and transmits the message to the terminal device. The time period of primary cell change can be reduced efficiently and the data transmission during the primary cell change can be optimized.
Patent MX-2019002213-A (MX)
Title: Egg candling and relocation apparatus for use with in ovo injection machines.
Inventor: CHRISTOPHER DAVIS LESLIE
IPC: A01K45/00
Filed: 2017-08-25
Abstract: The invention relates to a candling apparatus for the rapid discrimination, removal and relocation of non-live avian eggs. The invention further relates to methods of use of the candling apparatus for the candling, removal and relocation of avian eggs.
Patent MX-2019002540-A (MX)
Title: Device for electroerosion of two fluids.
Inventor: JESUS MANUEL ORONA HINOJOS
IPC: B23K35/02
Filed: 2019-03-05
Abstract: The present invention discloses EDM devices and methods for executing EDM machining. Said devices can perform electrical discharge machining and pulse electrochemical machining (S-ED/PEC) by its design in the electrode assembly and using two different working fluids.
Patent MX-2019004252-A (MX)
Title: Particulate nucleating agent, resin composition, molded article and method for manufacturing same.
Inventor: TAKUYA FUKUDA
IPC: C08K5/527
Filed: 2018-10-09
Abstract: This particulate nucleating agent contains an aromatic phosphate ester metal salt represented by a prescribed expression, wherein the spread WA of a particle diameter distribution before pressure treatment and the spread WB of a particle diameter distribution after pressure treatment satisfy the expression: 0.3=WA/WB=13.5.
Patent MX-2019004580-A (MX)
Title: Pharmaceutical formulations and methods of making the same.
Inventor: MONICA GOSS
IPC: A61P29/00
Filed: 2017-10-19
Abstract: The invention relates to the formulation of pharmaceutical compositions of etanercept. The invention also relates to methods of removing buffer and of formulating pharmaceutical compositions of etanercept.
Patent MX-2019005389-A (MX)
Title: Malodor counteractant composition and methods.
Inventor: MARVEL FIELDS
IPC: A61Q13/00
Filed: 2017-11-20
Abstract: The present invention relates to compositions and methods for malodor reduction. The malodor control compositions are suitable for use in a variety of applications, including use in consumer products, for example, air freshening compositions, laundry detergents, fabric enhancers, surface cleaners, beauty care products, dish care products, diapers, feminine protection articles, animal and pet litter compositions and plastic films for garbage bags. Such malodor control technologies do not unduly interfere with the scent of the perfumed or unperfumed situs that is treated with the malodor control technology.
Patent MX-2019007135-A (MX)
Title: Bycyclic heteroaryl derivatives as cftr potentiators.
Inventor: CHRISTOPH WOLFGANG ZAPF
IPC: A61K31/519
Filed: 2017-12-14
Abstract: The present invention relates to 1,3-disubstituted-1H-pyrazolo[3,4-d]pyrimidin-4-amine derivatives, 5,7-disubstituted-pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives or 5,7-disubstituted-imidazo[5,1-f][1,2,4]triazine-4-amine derivatives, and pharmaceutically acceptable salts thereof. The compounds are potentiators of Cystic Fibrosis Transmembrane conductance Regulator (CFTR). The invention also discloses pharmaceutical compositions comprising the compounds, optionally in combination with additional therapeutic agents, and methods of potentiating, in mammals, including humans, CFTR by administration of the compounds. These compounds are useful for the treatment of cystic fibrosis (CF), asthma, bronchiectasis, chronic obstructive pulmonary disease (COPD), constipation, Diabetes mellitus, dry eye disease, pancreatitis, rhinosinusitis, Sjogren's Syndrome, and other CFTR associated disorders.
Patent MX-2019007137-A (MX)
Title: Phenylamidines and the use thereof as fungicides.
Inventor: MAZEN ES-SAYED
IPC: A01P3/00
Filed: 2017-12-13
Abstract: The present invention relates to compounds of the formula (I), in particular to phenylamidines of the formula (I), to a process for their preparation, to the use of phenylamidines of the formula (I) according to the invention for controlling unwanted microorganisms, in particular phytopathogenic fungi and also to a composition for this purpose, comprising the phenylamidines of the formula (I) according to the invention. Furthermore, the invention relates to a method for controlling unwanted microorganisms, in particular phytopathogenic fungi, characterized in that the compounds of the formula (I) are applied to the microorganisms, in particular to the phytopathogenic fungi and/or in their habitat.
Patent MX-2019008478-A (MX)
Title: Automated material inventory and delivery system for underground mines.
Inventor: MARC BOUDREAU
IPC: E21F17/00
Filed: 2018-01-17
Abstract: The invention discloses an automated material inventory and delivery system for underground mines using a shaft and hoist transporting material from the surface to working areas. The system includes means for automatically and paperless processing orders for supplies from a plurality of locations within the mine. The system communicates to client through a plurality of terminals located throughout the mine and tracks material received, stored and distributed using electronic inventory tracking means. Loading and unloading of material into and out of the cage is automatic and includes automatic guided vehicle means to gather the ordered material and deliver to the cage. The system includes means whereby consumable supplies are autonomously delivered to a working area to ensure sufficient material is on hand to meet production targets. Ore may be transported to the surface using the cage and ore containers, optimizing the use of the hoist and increasing mine production.
Patent MX-2019010645-A (MX)
Title: Method for producing acetic acid.
Inventor: MASAHIKO SHIMIZU
IPC: C07C51/12
Filed: 2017-05-25
Abstract: Provided is a method whereby acetic acid that exhibits good results in a potassium permanganate test can be produced efficiently in an industrial manner without involving excessive cost. This method for producing acetic acid includes a carbonylation step, an evaporation step, a step of removing low boiling point substances, and a first overhead stream recycling step in which at least a part of an aqueous phase and/or an organic phase obtained by condensing a first overhead stream, which is obtained in the step of removing low boiling point substances, is recycled to a reaction vessel, wherein the method for producing acetic acid is characterized by controlling the concentration of crotonaldehyde to 2.2 ppm by mass or less in a first acetic acid stream obtained in the step of removing low boiling point substances. The catalyst system may further contain an ionic iodide. In addition, the method for producing acetic acid may further include an acetaldehyde separation and removal step for separating and removing acetaldehyde by distilling at least a part of the aqueous phase and/or organic phase obtained by condensing the first overhead stream.
Patent MX-2019011785-A (MX)
Title: Process for preparing chiral 2,3-dihydrothiazolo[3,2-a]pyrimidin- 4-ium compounds.
Inventor: JOACHIM DICKHAUT
IPC: A01N43/90
Filed: 2018-03-26
Abstract: The present invention relates to pyrimidinium compounds of formula (I), to the stereoisomers, salts, tautomers and N-oxides thereof, their mixtures and to compositions comprising such compounds or mixtures. The invention also relates to methods and uses of these pyrimidinium compounds and of compositions thereof, for combating and controlling animal pests. Furthermore, the invention relates also to pesticidal methods of applying such substituted pyrimidinium compounds. The pyrimidinium compounds of the present invention are defined by the following general formula (I), wherein R1, R2 and Het are defined as in the description.
Patent MX-2019011848-A (MX)
Title: Lotion and tonic for hair, scalp, and skin.
Inventor: PÉREZ RODRÍGUEZ VICTOR MANUEL
IPC: A61K8/97
Filed: 2019-09-25
Abstract: The present invention relates to a lotion for topical use and a tonic for oral consumption useful for hair, scalp (hair follicles), and skin, for cosmetic or medicinal use, any age women and men. It aims to prevent baldness or androgenetic alopecia, stop abnormal and excessive hair loss caused by different pathologies or causes, stimulate the hair follicle, beautify and thicken the hair, prevent graying, and recover the original lost hair color. Also, it is useful for skincare (removes age spots, cloth, and other skin problems) and facial complexion. Said lotion consists of rice water, potato peel water, garlic, colloidal silicon, colloidal copper, vitamin biotin, virgin honey, liquid oxygen, and pumpkin. Further, it is worth mentioning that the recovery of the original hair color or the prevention of gray hair takes more time.
Patent MX-2019012775-A (MX)
Title: Improved hygiene compliance monitoring.
Inventor: HÅKAN LINDSTRÖM
IPC: G06Q50/22
Filed: 2017-04-27
Abstract: A system for determining a hygiene compliance metric which indicates a usage of hygiene equipment, said system comprising distributed hygiene equipment arranged to dispense a hygiene consumable and/or to dispose of a hygiene consumable, a tag configured to at least transmit radio signals; positioning equipment arranged to determine information on a position of said tag by at least receiving radio signals from said tag, and configured to determine information on a direction along which a radio signal was received from said tag for determining said information on a position; and said processing entity which is configured to receive said information on a position of said tag, to define a zone into which said tag may enter, to define a rule, and to calculate said hygiene compliance metric based on said information on the position, said zone, and said rule.
Patent MX-2019015078-A (MX)
Title: Personal care device with audible feedback.
Inventor: STEPHAN JAMES ANDREAS MESCHKAT
IPC: A61B5/00
Filed: 2018-06-13
Abstract: A personal care device for modifying a keratinous surface having a sensor, a treatment element adapted to deposit a personal care composition, a feedback element, and a processor. The feedback element can be activated during deposition of the personal care composition. The personal care device can analyze a keratinous surface, identify keratinous imperfections, and then modify the keratinous imperfection by depositing a personal care composition. The feedback element can be intermittently activated during deposition and can emit a feedback signal that corresponds to the deposition of the personal care composition to alert the user as to how the personal care device is working and/or when the modification process is complete.
Patent MX-2020001661-A (MX)
Title: Ethane oxidative dehydrogenation.
Inventor: GUUS VAN ROSSUM
IPC: C07C11/04
Filed: 2018-08-02
Abstract: The invention relates to a process for oxidative dehydrogenation of ethane, comprising the steps of:(a) subjecting a stream comprising ethane to oxidative dehydrogenation conditions;(b) removing water from at least part of the effluent resulting from step (a);(c) optionally removing unconverted oxygen and/or carbon monoxide and/or ycetylene from at least part of the stream comprising ehtylene, unconverted ethane, carbon dioxide, optionally unconverted oxygen, optionally carbon monoxide and optionally acetylene resulting from step (b);(d) removing ethylene from at least part of the stream comprising ehtylene, unconverted ethane and carbon dioxide resulting from step (b) or (c) by a complexation separation method;(e) partially and selectively removing carbon dioxide from at least part of the stream comprising unconverted ethane and carbon dioxide resulting from step (d);(f) recycling at least part of the stream comprising unconverted ethane and carbon dioxided resulting from step (e) to step (a).
Patent MX-2020004820-A (MX)
Title: Door system for opening and closing a container opening of a furnace.
Inventor: SCHMITT MAX
IPC: F27D1/18
Filed: 2018-09-26
Abstract: The invention relates to a furnace, in particular a melting and/or holding furnace, comprising a container for receiving a melt, said container having an opening, and a door for closing and opening the opening. The furnace further comprises at least two first door hinges, which are arranged fixedly relative to the door and define a first door axis of rotation. The furnace also has at least one, preferably precisely one, second door hinge, which is arranged fixedly relative to the door and is at a distance from the first door axis of rotation. The furnace further comprises a first coupling device, which connects the door moveably to the container via the first door hinges, and a second coupling device, which connects the door moveably to the container via the second door hinge. It is particularly advantageous if precisely two first door hinges and precisely one second door hinge are arranged on the door. In this way, the door can be mounted and guided using precisely three hinges.
Patent MX-2020005354-A (MX)
Title: Cleansing compositions and use thereof.
Inventor: ZUNIGA ARTURO
IPC: C11D17/00
Filed: 2017-11-30
Abstract: A cleansing composition comprising an aqueous solution of an anionic polymer, a nonionic polymer and a system of surfactants. Solutions as described herein comprise two distinct aqueous phases having different compositions and density. Further methods of use are also disclosed.
Patent MX-2020005678-A (MX)
Title: Wireless communication systems with code-division multiple access and interference avoidance.
Inventor: CHURAN GARY
IPC: H04W72/04
Filed: 2018-11-30
Abstract: The present disclosure includes wireless communication systems with code-division multiple access with interference avoidance (CDMA-LA). In one embodiment, the wireless communication system includes a plurality of transmitters and a plurality of receivers. At least one transmitter of the plurality of transmitters is configured to detect unoccupied segments of spectrum occupancy of interference at one of the plurality of receivers, and spread power of a transmitted signal non-uniformly across a channel bandwidth that is much wider than an information bandwidth of the transmitted signal using a plurality of non-contiguous spectral segments that correspond to the unoccupied segments of the spectrum occupancy of the interference at the one of the plurality of receivers. At least one receiver of the plurality of receivers is configured to perform a demodulation process by coherently integrating the power of the transmitted signal over the plurality of non-contiguous spectral segments.
Patent MX-2020007712-A (MX)
Title: Portable automatic cryostat.
Inventor: BELTRÁN RAMÍREZ JESÚS RAÚL
IPC: G01N1/42
Filed: 2020-07-20
Abstract: The present invention discloses a portable automatic cryostat with integrated cooling means maintaining a temperature lower than the outside since its lid isolates the interior of the cryostat, thus protecting the samples from any possible contamination. Also, it has a cutting module and a sample collection module operating simultaneously, automatically, and independently. Further, it has a punctual temperature control system, which allows a temperature variation, managing to collect the samples by thermal difference.
Patent MX-2020007876-A (MX)
Title: Gene therapy for limb-girdle muscular dystrophy type 2c.
Inventor: RODINO-KLAPAC LOUISE R
IPC: A61K38/17
Filed: 2019-01-30
Abstract: The disclosure relates to gene therapy vectors, such as AAV vectors, comprising a polynucleotide encoding Î³-sarcoglycan (SGCG) and methods of using such gene therapy vectors to treat subjects suffering from a muscular dystrophy, e.g. limb girdle dystrophy type 2C (LGMD2C).
Patent MX-2020007882-A (MX)
Title: Fc variants with enhanced binding to fcrn and prolonged half-life.
Inventor: QIU HUAWEI
IPC: A61K39/00
Filed: 2019-01-25
Abstract: The present disclosure provides binding polypeptides (e.g., antibodies and immunoadhesins) comprising a modified Fc domain. The present disclosure also provides nucleic acids encoding the binding polypeptides, recombinant expression vectors, and host cells for making such binding polypeptides. Methods of using the binding polypeptides disclosed herein to treat disease are also provided.
Patent MX-2020008706-A (MX)
Title: Novel opioid compounds and uses thereof.
Inventor: CHANG PING
IPC: A61K31/485
Filed: 2019-02-22
Abstract: This invention relates to novel opioid derivatives of Formula I: or a pharmaceutically acceptable salt or solvate thereof, wherein R<sup>1</sup>, R<sup>3</sup>, R<sup>4</sup> and Z are as defined herein in the disclosure. The invention also relates to the use of such compounds for the treatment or prevention of, for example, pain.
Patent MX-2020009448-A (MX)
Title: Apparatus for making a beverage, comprising an image acquisition device.
Inventor: ACCURSI GIOVANNI
IPC: A47J31/44
Filed: 2019-02-28
Abstract: This invention relates to an apparatus (1) for making a beverage, comprising an infusion chamber (21) for a capsule containing a food substance, a transfer channel (32) which connects a capsule insertion opening (31) to the infusion chamber (21), an image acquisition device (4) for acquiring at least one image of a portion of the capsule. The image acquisition device (4) includes an optical sensor (42) facing towards an image capture zone (40) which is a stretch of the transfer channel (32). A viewing window (45), made of transparent material, is interposed between the optical sensor (42) and the image capture zone (40), the viewing window (45) having a first face (451 ) and a second face (452). The apparatus also comprises a heating device (6, 22), which is positioned in a first region (11 ) which is at a height lower than a second region (12) in which the viewing window (45) is positioned. The first region (11) and the second region (12) are in communication with each other. In use, the heating device (6, 22) heats air in the first region (11) and the heated air flows into the second region (12), where the heated air can make contact with the first face (451) and/or the second face (452) of the viewing window (45) and heat the viewing window (45).
Patent MX-2020010383-A (MX)
Title: Use of fubp1 inhibitors for treating hepatitis b virus infection.
Inventor: PEDERSEN LYKKE
IPC: C12N15/113
Filed: 2019-04-05
Abstract: The present invention relates to a FUBP1 inhibitor for use in treatment of an HBV infection, in particular a chronic HBV infection. The invention in particular relates to the use of FUBP1 inhibitors for destabilizing cccDNA, such as HBV cccDNA. The invention also relates to nucleic acid molecules, such as oligonucleotides including siRNA, shRNA and antisense oligonucleotides, which are complementary to FUBP1 and capable of reducing a FUBP1 mRNA. Also comprised in the present invention is a pharmaceutical composition and its use in the treatment and/or prevention of a HBV infection.
Patent MX-2020010421-A (MX)
Title: T-cell inducing vaccine composition combinations and uses thereof.
Inventor: GEORGES BERTRAND
IPC: A61K39/12
Filed: 2019-04-04
Abstract: Provided herein are vaccine combinations and methods for enhancing an antigen specific T cell induced response in a subject in need thereof. The methods combine systemic vaccination with a first composition containing a non-replicating viral vector encoding an antigen or immunogen containing one or more CD8+ T cell epitopes; and/or a second composition with micelles containing fluorocarbon-linked peptides, wherein each peptide linked to the fluorocarbon is: i) 15 to 75 amino acid residues long; ii) from the antigen or immunogen of the first composition; and, iii) contains one or more of the CD8+ T cell epitopes of the first composition from the antigen or immunogen to induce antigen specific CD8+ T cells; and optionally a third composition comprising an immune modulator composition.
Patent MX-2020010732-A (MX)
Title: Her2-targeting antigen binding molecules comprising 4-1bbl.
Inventor: FERRARA KOLLER CLAUDIA
IPC: A61K39/395
Filed: 2019-04-12
Abstract: The invention relates to Her2 targeting 4-1BB agonists, in particular 4-1BBL trimercontaining antigen binding molecules comprising at least one antigen binding domain capable of specific binding to Her2 and their use in the treatment of cancer as well as their use in combination with T-cell activating anti-CD3 bispecific antibodies.
Patent MX-2020010820-A (MX)
Title: Pharmaceutical combination products comprising a histone deacetylase (hdac) inhibitor and a tlr7 agonist and/or tlr8 agonist for the treatment of cancer.
Inventor: HAMM SVETLANA
IPC: C07D401/12
Filed: 2019-04-15
Abstract: The invention relates to pharmaceutical combination products comprising an HDAC inhibitor, e.g. (E)-N-(2-amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benze nesulfonyl]-1H-pyrrol-3-yl}- acrylamide as well as salts and or solvents thereof and TLR7 agonist and/or TLR8 agonist for the treatment of cancer. The present invention also relates to methods of treatment of patients suffering from cancer with these pharmaceutical combination products.